Arrowhead Publishers Research Reports

Title	Published	Price
The Global Pain Therapeutics Market Market Analysis, R&D Pipelines and Competitive Landscape By: Arrowhead Publishers One in five people suffer from moderate to severe chronic pain, and one in three is unable or less able to maintain an independent lifestyle due to their pain. Between 50 and 60 percent of \| more... Search inside this report	10/29/2007	$2,999.00
The Global Antibacterials Market: R&D Pipelines, Market Analysis and Competitive Landscape By: Arrowhead Publishers The global anti-infective market is currently valued at US$66.5 billion with antibacterial agents accounting for over 50% of sales. The antibacterial market is set to grow to over US$45.0 billion by 2012, driven by the \| more... Search inside this report	8/28/2007	$2,499.00
The Global Antivirals Market: R&D Pipelines, Market Analysis and Competitive Landscape By: Arrowhead Publishers The global anti-infective market is currently valued at US$66.5 billion with antiviral agents accounting for 24% of sales (excluding vaccines which target viral infectious diseases). According to Arrowhead Publishers’ new report The Antivirals Market: \| more... Search inside this report	5/17/2007	$2,499.00
Outsourcing Clinical Trials: A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index By: Arrowhead Publishers Offshoring clinical trials to emerging markets around the world is receiving increasing attention as a very attractive alternative in the clinical development process. This follows as a natural reaction to already successful offshoring activities in \| more... Search inside this report	5/1/2007	$2,999.00
Innovations and Trends in Clinical Trials: Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology By: Arrowhead Publishers The clinical trials industry has clear potential for strong growth in the future, driven by technological and scientific advances. This trend is complemented by the development of new trial designs, with a view to rationalizing \| more... Search inside this report	3/8/2007	$2,250.00
Neurodegenerative Disorder Therapies By: Arrowhead Publishers With a market size of US$14.5 billion in 2005 and an anticipated value of US$16.5 billion in 2006, the neurodegenerative market represents a valuable, fast-growing opportunity in the pharma/biotech industry. An increase in the number \| more... Search inside this report	1/31/2007	$2,250.00
Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight By: Arrowhead Publishers In 2005, the antibodies market was valued at an estimated US$14 billion, accounting for over 24 percent of the total protein therapeutics market. This share increased substantially since 2001, when it barely surpassed 13 percent. \| more... Search inside this report	1/11/2007	$2,250.00
The Global Protein Therapeutics Market: Market Dynamics and Pipeline Analysis By: Arrowhead Publishers The global protein therapeutics market was valued at US$57 billion in 2005. Biotechnology has made notable inroads in the field of protein therapeutics, resulting in some of the key products presently available in the category. \| more... Search inside this report	12/7/2006	$3,250.00
Injectable Drug Delivery: Market Impact and Industry Trends By: Arrowhead Publishers As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors. The search for more efficient drug delivery systems is also being driven \| more... Search inside this report	10/3/2006	$1,750.00
Rheumatoid Arthritis: Market Trends and R&D Insights By: Arrowhead Publishers "The market for rheumatoid arthritis therapeutics has experienced remarkably strong growth during the past five years due to the introduction of the biological response modifiers (BRMs) to treatment regimens. The value of this market \| more... Search inside this report	9/20/2006	$1,250.00
The Prescribing Data Restriction Program: Critical Assessment and Best Practices By: Arrowhead Publishers Since the mid-1990s, pharma companies have devised their sales and marketing strategies based on Rx data. However, with the introduction of the AMA's Prescribing Data Restriction Program (PDRP) opt-out program in July 2006, pharma companies \| more... Search inside this report	9/10/2006	$1,500.00
The Global Diabetes Market: Therapeutics, Diagnostics and Complications By: Arrowhead Publishers Diabetes is one of the largest therapeutic segments of global pharmaceutical sales and during the last 10 years it has grown by a compound average growth rate of nearly 20% from around US$4 billion in \| more... Search inside this report	8/1/2006	$2,499.00
The Global Drug Delivery Market: Research Trends and Market Outlook By: Arrowhead Publishers The drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products. Drug delivery companies not only stand to benefit \| more... Buy by the section \| Search inside this report	5/1/2006	$1,999.00
Biotech in Autoimmune and Inflammatory Disease 2006, 2nd Edition By: Arrowhead Publishers Despite their diversity, global healthcare systems are increasingly converging in the need and desire to contain costs of healthcare, and especially those associated with pharmaceuticals. At the same time, Big Pharma are having \| more... Search inside this report	5/1/2006	$2,999.00
Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006 By: Arrowhead Publishers Despite their diversity, global healthcare systems are increasingly converging in the need and desire to contain costs of healthcare, and especially those associated with pharmaceuticals. At the same time, Big Pharma are having \| more... Search inside this report	3/1/2006	$1,999.00
Cancer Therapeutics 2006: Market Dynamics and R&D Trends By: Arrowhead Publishers Together, the four major cancer markets, which include colorectal, prostate, lung and breast cancer were valued at well over $16 billion in 2005, which was an increase of 14 percent in value since 2004. \| more... Buy by the section \| Search inside this report	12/1/2005	$2,500.00
Amgen: Profile, Patents and Pipeline By: Arrowhead Publishers Amgen is the world’s largest biotechnology company and the eighth largest pharmaceutical company worldwide. Revenues have nearly doubled in the last three years, going from $5.52 billion in 2002 to $10.55 billion in 2004. \| more...	8/1/2005	$499.00
US and European Prescription Generic Markets: An Examination of Commercial and Regulatory Contrasts By: Arrowhead Publishers The US generics market was estimated at US$18.1 billion in 2004; the leading European generics markets together totalled between US$10-US$11 billion for the same period. This new report asks why there is such \| more...	7/1/2005	$1,125.00
Pain Therapeutics 2005: Market Dynamics and Outlook By: Arrowhead Publishers Pain Therapeutics 2005: Market Dynamics and Outlook provides detailed analysis and information concerning the global market for pain therapeutics, R&D pipelines and company involvement in this field. About one and a half billion people \| more... Buy by the section \| Search inside this report	5/1/2005	$1,999.00
Strategies for Innovation in Pharmaceutical R&D: Enhancing R&D Through Biotech Alliances and CRO Outsourcing By: Arrowhead Publishers This new report has been written to provide members of pharmaceutical, biotechnology and clinical research sectors an analytically-based overview of the mechanisms of the partnering process, and the key issues and trends affecting these arrangements. \| more...	4/1/2005	$750.00
Biogenerics: Challenges and Promise By: Arrowhead Publishers This brand new report published in November 2004 takes an insightful look at the burgeoning biogenerics industry. This report primarily focuses on how the generics industry will be shaped by the global \| more... Search inside this report	1/1/2005	$999.00
Cancer Vaccines: Measuring Market Potential By: Arrowhead Publishers This brand new report published in October 2004 provides an overview of the emerging market for cancer vaccines and measures their potential impact on a number of cancer markets. Vaccine product candidates are \| more...	10/1/2004	$1,500.00
Title	Published	Price

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2008, All Rights Reserved, MarketResearch.com
7/5/2008 - 4